It is unclear why this report differs from the majority of other studies, but it highlights that not all studies support the role of CDKN2A/B HD as a prognostic marker in IDH-mutant astrocytomas. The gene discussed is IDH2; the disease is astrocytoma (excluding glioblastoma).